All-Trans-Retinoic Acid and Pseudotumor Cerebri

References

• Huang M. E., Ye Y. C., Chen S. R. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–72
   PubMed Web of Science ®Google Scholar
• Degos L., Chomienne C., Daniel M. T., Berger L., Dombret H., Fenaux P., Castaigne S. Treatment of first relapse in acute promyelocytic leukemia with all-trans retinoic acid. The Lancet 1990; 336: 1440–1
   PubMed Web of Science ®Google Scholar
• Castaigne S., Chomienne C., Daniel M. T. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990; 76: 1704–9
   PubMed Web of Science ®Google Scholar
• Warrell R. P., Frankel S. R., Miller W. H., Scheinberg D. A., Itri L. M., Hittelman W. N., Vyas R., Andreef M., Tafuri A., Jakubowski A., Gabrilove J., Gordon M. S., Dmitrovsky E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). The New England Journal of Medicine 1991; 324: 1385–93
   PubMed Web of Science ®Google Scholar
• Chen Z. X., Xue Y. Q., Zhang R. I. A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood 1991; 78: 1413–9
   PubMed Web of Science ®Google Scholar
• Warrell R. P., Frankel S. R., Miller W. H., Eardley A., Dimitrovsky E. All-trans retinoic acid (RA) for remission induction of acute promyelocytic leukemia (APL) results of the New York study. Blood 1992; 80, suppl. 360a, 1429
   Google Scholar
• Smith M. A., Adamson P. C., Balis F. M., Feusner J., Aronson L., Murphy R. F., Horowitz M. E., Reaman G., Hammond G. D., Fenton R. M., Connaghan G. D., Hittelman W. N., Poplack D. G. Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer. Journal of Clinical Oncology 1992; 10: 1666–73
   PubMed Web of Science ®Google Scholar
• Warrell R. P., De ThÈ H., Wang Z., Degos L. Acute promyelocytic leukemia. The New England Journal of Medicine 1993; 329: 177–89
   PubMed Web of Science ®Google Scholar
• Sidell N. Retinoic acid induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. Journal of National Cancer Institute 1982; 68: 589–93
   PubMed Web of Science ®Google Scholar
• Sidell N., Altman A., Haussler M. Effect of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines. Experimental Cell Research 1983; 148: 21–30
   PubMed Web of Science ®Google Scholar
• Strickland S., Mahdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 1978; 15: 393–408
   PubMed Web of Science ®Google Scholar
• Andrews P. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Developmental Biology 1984; 103: 285–293
   PubMed Web of Science ®Google Scholar
• Crouch G., El-Badry O., Helman L. (1978) All-trans retinoic acid inhibition of cell growth in human rhabdomyosarcoma cell lines is not directly mediated through IGF-II. Proceedings of American Association of Cancer Research 1990; 31:29. 1990
   Google Scholar
• Thein R., Lotan R. Sensitivity of cultured human osteosarcoma and chondrosarcoma cells to retinoic acid. Cancer Research 1982; 2: 4771–75
   Google Scholar
• Miser J., Kinsella T., Triche T., Tsokos M., Forquer R., Wesley R., Horvat K., Belasco J., Longo D. L., Steis R., Glatstein E., Pizzo P. A. Preliminary results of treatment of Ewing's sarcoma of bone in children and young adults: Six months of intensive combined modality therapy without maintenance. Journal of Clinical Oncology 1988; 6: 484–90
   PubMed Web of Science ®Google Scholar
• Arbaje Y. M., Bittner G., Yingling J. M., Storer B., Schiller J. H. Antiproliferative effects of interferone alfa and beta in combination with 5-fluorouracil, cisplatin. and cis- and transretinoic acid in three human lung carcinoma cell lines [abstract]. Journal of Interferon Research 1993; 13: 25–32
   PubMedGoogle Scholar
• Parkinson D. R., Smith M. A., Cheson B. D., Stevenson H. C. Trans-retinoic acid and related differentiation agents. Seminars in Oncology 1992; 19: 734–41
   PubMed Web of Science ®Google Scholar
• Agarwal C., Rorke E. A., Boyce M., Howard J., Crish J., Hufeisen S., Eckert R. L. Retinoid-dependent transcriptional suppression of cytokeratin gene expression in human epidermal squamous cell carcinoma cells. Differentiation 1993; 52: 185–91
   PubMed Web of Science ®Google Scholar
• Sizemore N., Rorke E. A. Human papillomavirus 16 immortalization of normal human ectocervical epithelial cells alters retinoic acid regulation of cell growth and epidermal growth factor receptor expression. Cancer Research 1993; 53: 4511–7
   PubMed Web of Science ®Google Scholar
• Redfern C. P., Daly A. K., Latham J. A., Todd C. The biological activity of retinoids in melanoma cells. Induction of expression of retinoic acid receptor beta by retinoic acid in S91 melanoma cells. FEBS Letters 1990; 273: 19–22
   PubMed Web of Science ®Google Scholar
• Edward M., Gold J. A., Mackie R. M. Retinoic acid-induced inhibition of metastatic melanoma cell lung colonization and adhesion to endothelium and subendothelial extracellular matrix [abstract]. Clinical and Experimental Metastasis 1992; 10: 61–7
   PubMed Web of Science ®Google Scholar
• Frankel S. R., Eardley A., Lawers G., Weiss M., Warrell R. P. The “retinoic acid syndrome” in acute promyelocytic leukemia. Annals of Internal Medicine 1992; 117: 292–96
   PubMed Web of Science ®Google Scholar
• Spoor T. C., Ramocki J. M. Treatment of pseudotumor cerebri by primary and secondary optic nerve sheat decompression. Am. J. Ophtal. 1991; 112: 177
   PubMed Web of Science ®Google Scholar
• Wald S. L. Disorders of cerebrospinal fluid circulation and brain edema. Neurology in Clinical Practice, W. G. Bradley, R. B. Daroff, G. M. Fenichel, C. D. Marsden. Butter-worth-Heinemann, Boston London Singapore Sydney Toronto Wellington 1991; 1211–38
   Google Scholar
• Radhakrishnan K., Ahlskog J. E., Cross S. A., Kurland L. T., O'Fallon W. M.). Idiopathic intracranial hypertension—Descriptive epidemiology in Rochester. Minn. 1976 to 1990. Archives of Neurology 1993; 50: 78–80
   PubMed Web of Science ®Google Scholar
• Adam R. D., Victor M. Distrubance of cerebrospinal fluid circulation, including hydrocephalus and meningeal reactions. Principles of Neurology, R. D. Adam, M. Victor. Mc Graw-Hill, New York 1993; 539–53
   Google Scholar
• Boeri R. The pseudotumor cerebri. Current Opinion in Neurology 1994; 7: 69–73
   PubMed Web of Science ®Google Scholar
• Corbett J. J. The 1982 Silverside lecture. Problems in the diagnosis and treatment of pseudotumor cerebri. The Canadian Journal Of Neurological Sciences 1983; 10: 221–229
   PubMed Web of Science ®Google Scholar
• Digre K. B., Corbett J. J. Pseudotumor cerebri in man. Archives of Neurology 1988; 45: 866–72
   PubMed Web of Science ®Google Scholar
• Sorensen P. S., Krogsaa B., Gjerris F. Clinical course and prognosis of pseudotumor cerebri. A prospective study of 24 patients. Acta Neurologica Scandinava 1988; 77: 164–72
   PubMed Web of Science ®Google Scholar
• Wall M., George D. Idiopathic Intracranial Hypertension. A prospective study of 50 patients. Brain 1990; 114: 155–80
   Web of Science ®Google Scholar
• Lessel S. Pediatric pseudotumor cerebri (idiopathic intracranial hypertension). Survey of Ophthalmology 1992; 37: 155–66
   PubMed Web of Science ®Google Scholar
• Hier D. B. Headache. Manual of Neurologic Therapeutics, A. M. Samuel. Little, Brown and Company, Boston New York Toronto London 1995; 18–33
   Google Scholar
• Sorensen P. S., Corbett J. J. High cerebrospinal fluid pressure. The Headaches, edited by Olesen, J. Tfelt-Hansen, K. M. A. Pwelch. Raven Press Ltd, New York 1993; 679–86
   Google Scholar
• Durcan F. J., Corbett J. J., Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Archives of Neurology 1988; 45: 875–77
   PubMed Web of Science ®Google Scholar
• Radhakrishnan K., Sridharan R., Ashok P. P., Mousa M. E. Pseudotumor cerebri: incidence and pattern in North-Eastern Libya. European Neurology 1986; 25: 117–24
   PubMed Web of Science ®Google Scholar
• Ahlskog J. E., O'Neill B. P. Pseudotumor cerebri. Annals of Internal Medicine 1982; 97: 249–56
   PubMed Web of Science ®Google Scholar
• Askmark H., Lundberg P. O., Olsson S. Drug-related headache. Headache 1989; 29: 441–4
   PubMed Web of Science ®Google Scholar
• Griffin J. P. A review of the literature on benign intracranial hypertension associated with medication. Adverse Drug Reaction and Toxicological Review 1992; 11: 41–57
   PubMedGoogle Scholar
• Verderber L., Lavin P., Wesley R. Pseudotumor cerebri and chronic benzene hexachloride (lindane) exposure [letter]. Journal of Neurology Neurosurgery and Psychiatry 1991; 54: 1123
   PubMed Web of Science ®Google Scholar
• Lubetzki C., Sanson M., Cohen D., Schaison-Cusin M., Lhermitte F., Lyon-Caen O. Hypertension intracranienne benigne et minocycline. Revue Neurologique 1988; 144: 218–20
   PubMedGoogle Scholar
• Lander C. M. Minocycline induced benign intracranial hypertension [abstract]. Clinical and Experimental Neurology 1989; 26: 161–7
   PubMedGoogle Scholar
• Bove L., Compagnoni L., Lanzetti A., Nappo A. A Hypertensione intracranienne benigne et minocycline. Une observation. Revue Neurologique 1990; 146: 158
   PubMedGoogle Scholar
• Donnet A., Dufour H., Graziani N., Grisoli F. Minocycline and benign intracranial hypertension. Biomedicine and Pharmacotherapy 1992; 6: 171–2
   Web of Science ®Google Scholar
• Moskowitz Y., Leibowitz E., Ronen M., Aviel E. Pseudotumor cerebri induced by vitamin A combined with minocycline [abstract]. Annals of Ophthalmology 1993; 25: 306–8
   PubMed Web of Science ®Google Scholar
• Winrow A. P., Supramaniam G. Benign intracranial hypertension after ciprofloxacin administration. Archives of Disease in Childhood 1990; 65: 1165–6
   PubMed Web of Science ®Google Scholar
• Getenet J. C., Croisile B., Vighetto A., Grochowicki M., Goudable B., Aimard G., Trillet M. Idiopathic intracranial hypertension after ofloxacin treatment. Acta Neurologica Scandinava 1993; 87: 503–4
   PubMed Web of Science ®Google Scholar
• Heudier P., Chichmanian R. M., Taillan B., Gratecos N., Fuzibet J. G., Dujardin P. Hypertension intracranienne benigne medicamenteuse. A propos d'un cas rapporte a l'amphotericine B. Revue de la litterature. Therapie 1992; 47, 403–7
   PubMedGoogle Scholar
• Mukherjee A., Dutta P., Lahiri M., Sinha S., Mitra A. K., Bhattacharya S. K. Benign intracranial hypertension after nalidixic acid overdose in infants [letter]. The Lancet 1990; 335: 1602
   PubMed Web of Science ®Google Scholar
• Kortzes A., Rathaus M., Chen B., Bernheim J. Pseudotumor cerebri and nitrofurantoin [letter]. Drug Intelligence and Clinical Pharmacy 1988; 22: 345
   Google Scholar
• Del Brutto O. H. Delayed CSF reaction to praziquantel. The Lancet 1988; 2: 341
   PubMed Web of Science ®Google Scholar
• Murgia S., Del Curto E., Zecca G. Ipertensione endocranica benigna da sulfenazone. Pediatria Oggi Medica e Chirurgica 1989; 11: 541–2
   PubMedGoogle Scholar
• Falcini F., Taccetti G., Montanelli F., Tafi L., Volpi M. Ipertensione endocranica benigna in corso di terapia con acido acetilsalicilico: segnalazione di due casi in età pediatrica. Pediatria Oggi Medica e Chirurgica 1989; 11: 319–21
   PubMedGoogle Scholar
• Borruat F. X., Regli F. Pseudotumor cerebri as a complication of amiodarone therapy. American Journal of Ophthalmology 1993; 1, 16, 776–7
   Google Scholar
• Vemay D., Thevenet J. P., Tournilhac M. Encephalopathie iatrogene au danazol. Therapie 1988; 43: 501
   Google Scholar
• Hamed L. M., Glaser J. S., Schatz N. J., Perez T. H. Pseudotumor cerebri induced by danazol. American Journal of Ophthalmology 1989; 107: 105–10
   PubMed Web of Science ®Google Scholar
• Loukili M., Cordonnier M., Capelluto E., Neve P. Pseudo-tumeur cerebri induit par danazol [abstract]. Bulletin de la Societè Belge d'Ophtalmologie 1990; 239: 139–44
   PubMedGoogle Scholar
• Fanous M., Hamed L. M., Margo C. E. Pseudotumor cerebri associated with danazol withdrawal [letter]. JAMA 1991; 266: 1218–9
   PubMed Web of Science ®Google Scholar
• Schmitz U., Honisch C., Zierz S. Pseudotumor cerebri and carpal tunnel syndrome associated with danazol therapy [letter]. Journal of Neurology 1991; 38: 355
   Web of Science ®Google Scholar
• Tully M. P., Cooper R. G., Jayson M. I. Intracranial hypertension associated with stanazolol [letter]. DICP. The Annals of Pharmacotherapy 1990; 24: 1234
   Web of Science ®Google Scholar
• Saul R. F., Hamburger H. A., Selhorst J. B. Pseudotumor cerebri secondary to lithium carbonate. JAMA 1985; 253: 2869–70
   PubMed Web of Science ®Google Scholar
• Alvarez Cermeno J. C., Fernandez J. M., O'Neill Of Tyrone A., Moral L., Saiz-Ruiz J. Lithium-induced headache. Headache 1989; 29: 246–7
   PubMed Web of Science ®Google Scholar
• D'Anglejan-Chatillon J., Schaison M., Berche M., Goujon C., Caroli F., Bousser M. G. Deux complications neuro-ophthalmologiques rares d'un traitment au long cours par les sels de lithium. Encephale 1989; 15: 415–7
   PubMedGoogle Scholar
• Levine S. H., Puchalski C. Pseudotumor cerebri associated with lithium therapy in two patients. Journal of Clinical Psychiatry 1990; 51: 251–3
   PubMed Web of Science ®Google Scholar
• Domisse J. Pseudotumor cerebri associated with lithium therapy in two patients [letter]. Journal Of Clinical Psychiatry 1991; 52: 239
   Web of Science ®Google Scholar
• Arber N., Shirin H., Fadila R., Melamed E., Pinkhas J., Sidi Y. Pseudotumor cerebri associated with leuprorelin acetate [letter]. The Lancet 1990; 335: 668
   PubMed Web of Science ®Google Scholar
• Haller J. S., Meyer D. R., Cromie W., Fagles N., Hayes S. Pseudotumor cerebri following beta-human chorionic gonadotropin hormone treatment for undescended testicles. Neurology 1993; 43: 448–9
   PubMed Web of Science ®Google Scholar
• Evers J. P., Jacobson R. J., Pincus J., Zwiebel J. A. Pseudotumor cerebri following high-dose cytosine arabinoside. British Journal of Haematology 1992; 80: 559–60
   PubMed Web of Science ®Google Scholar
• Snodgrass S. R. Vitamin neurotoxicity [abstract]. Molecular Neurobiology 1992; 6: 41–73
   PubMed Web of Science ®Google Scholar
• Farris W. A., Erdman J. W. Protracted hypervitaminosis A following long-term, low-level intake. JAMA 1982; 247: 1317–8
   PubMed Web of Science ®Google Scholar
• Fishman R. A. Pathophysiology of pseudotumor. Annals of Neurology 1979; 5: 496
   PubMed Web of Science ®Google Scholar
• Donaldson J. O. Pathogenesis of pseudotumor cerebri syndromes. Neurology 1981; 31: 877–80
   PubMed Web of Science ®Google Scholar
• Bjerre P., Lindholm J., Gyldensted C. Pseudotumor cerebri. A theory on etiology and pathogenesis. Acta Neurologica Scandinava 1982; 66: 472–81
   PubMed Web of Science ®Google Scholar
• Fishman R. A. The pathophysiology of pseudotumor cerebri. An unsolved puzzle. Archives of Neurology 1984; 41: 257–58
   PubMed Web of Science ®Google Scholar
• Milhorat T. H. Classification of the cerebral edemas with reference to hydrocephalus and pseudotumor cerebri. Child's Nervous System 1992; 8: 301–6
   PubMed Web of Science ®Google Scholar
• De ThÈ H., Chomienne C., Lanotte M., Degos L., Dejean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alfa gene to a novel transcribed locus. Nature 1990; 347: 558–61
   PubMed Web of Science ®Google Scholar
• De ThÈ H., Lavau C., Marchio A., Chomienne C., Degos L., Dejean A. The PML-RARalfa fusion mRNA generated by the t(15;17) translocation in acute promyelocytic lekemia encodes a functionally altered RAR. Cell 1991; 66: 675–84
   PubMed Web of Science ®Google Scholar
• Kakizuka A., Miller W. H., Umesono K., Warrell R. P., Frankel S. R., Murty V. V. V. S., Dmitrovsky E., Evans R. M. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARalfa with a novel putative transcription lactor, PML. Cell 1991; 66: 663–74
   PubMed Web of Science ®Google Scholar
• Maden M., Ong D. E., Chytil F. Retinoid-binding protein distribution in the developing mammalian nervous system. Development 1990; 109: 75–80
   PubMed Web of Science ®Google Scholar
• Ruberte E., Friederich V., Chambon P., Morris-Kay G. Retinoic acid receptors and cellular retinoid binding proteins. III. Their differential transcript distribution during mouse nervous system development. Development 1993; 118: 267–82
   PubMed Web of Science ®Google Scholar
• Perez-Castro A. V., Toth-Rogler L. E., Wei L. N., Nguyen-Huu M. C. (1978) Spatial and temporal pattern of expression of the cellular retinoic acid-binding protein and the cellular retinol-binding protein during mouse embryogenesis. Proceedings of National Academy of Sciences USA 1989; 86:8813–7. 1989
   Google Scholar
• Maden M., Holder N. The involvement of retinoic acid in the development of the vertebrate central nervous system. Development, Suppl 1991; 2: 87–94
   Google Scholar
• Evans R. M. The steroid and thyroid hormone receptor superfamily. Science 1988; 240: 889–95
   PubMed Web of Science ®Google Scholar
• Maden M., Holder N. Retinoic acid and development of the central nervous system. Bioessays 1992; 14: 431–8
   PubMed Web of Science ®Google Scholar
• Momoi T., Hanaoka K., Momoi M. Spatial and temporal expression of cellular retinoic acid binding protein (CRABP) along the anteroposterior axis in the central nervous system of mouse embryos. Biochemical and Biophysical Research Communications 1990; 163: 991–6
   Web of Science ®Google Scholar
• Marcus R., Coulston A. M. Fat-soluble vitamins, A K. Vitamins, E. Goodman, A. Goodman Gilman, T. W. Roll, A. S. Nies, P. Taylor. Pergamon Press, New York Oxford Beijing Frankfurt Sao Paulo Sydney Tokyo Toronto 1990; 1553–71, Gilman's The pharmacological basis of therapeutics
   Google Scholar
• Johnston I., Paterson A. Benign intracranial hypertension. I. Diagnosis and prognosis. Brain 1974; 97: 289–300
   PubMed Web of Science ®Google Scholar
• Repka M. X., Savino P. J. Pseudotumor cerebri. American Journal of Ophthalmology 1984; 98: 741–6
   PubMed Web of Science ®Google Scholar
• Smith J. L. Whence pseudotumor cerebri?. Journal of Clinical Neuro-Ophthalmology 1985; 5: 55–6
   PubMedGoogle Scholar
• Corbett J. J., Thompson H. S. The rational management of idiopathic intracranial hypertension. Archives of Neurology 1989; 46: 1049–51
   PubMed Web of Science ®Google Scholar
• Lipton H. L., Michelson P. E. Pseudotumor cerebri syndrome without papilledema. JAMA 1972; 220: 1591–92
   PubMed Web of Science ®Google Scholar
• Scanarini M., Mingrino S., S'Avella D., Della-Cort V. Benign intracranial hypertension without papilledema: a case report. Neurosurgery 1979; 5: 376–7
   PubMed Web of Science ®Google Scholar
• Spence J. D., Amacher A. L., Willis N. R. Benign intracranial hypertension without papilledema: role of 24 hour cerebrospinal fluid pressure monitoring in diagnosis and management. Neurosurgery 1980; 7: 326–36
   PubMed Web of Science ®Google Scholar
• Marcelis J., Silberstein S. D. Idiopathic intracranial hypertension without papilledema. Archives of Neurology 1991; 48: 392–99
   PubMed Web of Science ®Google Scholar
• Mahmoud H. H., Hurwitz C. A., Roberts W. M., Santana V. M., Ribeiro R. C., Krance R. A. Tretinoin toxicity in children with acute promyelocytic leukaemia. The Lancet 1993; 342: 1394–95
   PubMed Web of Science ®Google Scholar
• Visani G., Bontempo G., Manfroi S., Pazzaglia A., D'Alessandro R., Tura S. All-trans-retinoic acid and pseudotumor cerebri in a young adult with acute promyelocytic leukemia: a possible disease association. Haematologica 1996; 81: 152–156
   PubMedGoogle Scholar